- Report of Foreign Issuer (6-K)
2010年10月26日 - 5:49AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2010
Commission File Number: 1-32186
YM BIOSCIENCES INC.
(Translation of registrant's name into English)
|
|
Suite 400, Building 11
5045 Orbiter Drive
Mississauga, Ontario
Canada L4W 4Y4
(Address of principal executive offices)
|
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1)
o
Note:
Regulation S-T Rule 101(b)(1) only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7)
o
Note:
Regulation S-T Rule 101(b)(7) only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been the subject of a Form 6-K submission or other Commission filing on EDGAR.
INCORPORATION BY REFERENCE
This Form 6-K is hereby incorporated by reference into the registration statement on Form S-8 (File No. 333-134410), and exhibit 99.1 is incorporated as an exhibit to the registration statement on Form F-10 (File No. 333-161786), of YM BioSciences Inc.
DOCUMENTS FILED
See the Exhibit Index hereto.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
YM BIOSCIENCES INC.
|
|
|
|
|
|
By:
|
/s/ Leonard Vernon
|
|
|
Leonard Vernon
Vice President, Finance and Administration
|
Date: October 25, 2010
EXHIBIT INDEX
Exhibit
|
|
Description
|
|
|
|
99.1
|
|
Management Proxy Circular
|
99.2
|
|
Form of Proxy
|
YM Biosciences (AMEX:YMI)
過去 株価チャート
から 7 2024 まで 8 2024
YM Biosciences (AMEX:YMI)
過去 株価チャート
から 8 2023 まで 8 2024
Real-Time news about YM Biosciences Ordinary Shares (Canada) (アメリカ証券取引所): 0 recent articles
その他のニュース記事